Section Arrow
EOCN.NASDAQ
- Eocene Ltd.
Quotes are at least 15-min delayed:2026/10/26 16:01 EDT
After Hours
Last
 --
-- (--)
Bid
2.51
Ask
3.15
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 3.15
+0.12 (+3.96%)
Day High 
3.28 
Prev. Close
3.03 
1-M High
3.7999 
Volume 
3.32K 
Bid
2.51
Ask
3.15
Day Low
3.1 
Open
3.1 
1-M Low
2.33 
Market Cap 
3.24M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 3.04 
20-SMA 3.28 
50-SMA 3.7 
52-W High 12.3192 
52-W Low 2.33 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-14.29/-2.17
Enterprise Value
3.24M
Balance Sheet
Book Value Per Share
11.92
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AZTRAzitra1.6+0.885+123.78%3.58PE
After Hours -- -- --
SPRCSciSparc Ltd.1.25+0.16+14.68%0PE
After Hours -- -- --
VBIOValion Bio Inc.0.84-0.1-10.64%-- 
After Hours -- -- --
MRNAModerna197.71-2.39-1.19%-- 
After Hours -- -- --
NAUTNautilus Biotechnolgy2.405-0.835-25.77%-- 
After Hours -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices forpostoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.